Canada Bio Decontamination Market Insights Forecasts to 2033

• The Market is growing at a CAGR of 7.3% from 2023 to 2033
• The Canada Bio Decontamination Market Size is expected to hold a significant share by 2033

The Canada Bio Decontamination Market is anticipated to hold a significant share by 2033, growing at a CAGR of 7.3% from 2023 to 2033. The increasing prevalence of hospital-acquired infections, rising number of surgical procedures, growth in the pharmaceutical & biotechnology industry, and increasing outsourcing of bio-contamination services are driving the growth of the bio decontamination market in the Canada.     

Market Overview

Bio decontamination refers to the process of eliminating all forms of microbial life. Various methods such as chemical disinfection, physical methods like heat or radiation, or biological approaches, which use enzymes or bacteriophages are used for this process. Numerous healthcare, pharmaceutical, and research organizations that need to maintain high standards of cleanliness to avoid health risks from biological pathogen exposure may require bio decontamination services. The adoption of technological advancements and the growing emphasis on quality care in order to meet client demands leads to increasing usage of biocontamination products and services.  In-house bio decontamination capabilities can be complex to set up and manage. Service providers can combine their resources from several clients, outsourcing enables them to take advantage of economies of scale, which could save healthcare facilities money and boost market expansion.

Report Coverage

This research report categorizes the market for the Canada bio decontamination market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Canada bio decontamination market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Canada bio decontamination market.

Driving Factors

A healthcare-associated infection affects one out of every nine hospital patients in Canada. It is estimated that about 220,000 instances of HAI occur in Canadian hospitals annually, leading to at least 8,000 fatalities. The increased prevalence of hospital-acquired infections in the country is responsible for driving the market. Bio decontamination is required to prevent the spread of infections and ensure patient safety. The rising number of surgical procedures is contributing to propel the market demand. The increasing pharmaceutical & biotechnology industry owing to the increasing R&D services and medical instrument manufacturing are driving the market demand. In addition, increasing outsourcing of bio-contamination services to third-party providers contributes to propelling the market growth.

Restraining Factors

The increasing adoption of single-use medical devices is restraining the bio decontamination market. Further, the availability of alternative strategies for microbial remediation is hindering market growth.

Market Segmentation

The Canada Bio Decontamination Market share is classified into product, type, agent, and end user.

• The equipment segment dominated the market with the largest market share during the forecast period.

The Canada bio decontamination market is segmented by product into equipment and consumables. Among these, the equipment segment dominated the market with the largest market share during the forecast period. To provide quick and complete cleaning, cutting-edge technologies like vaporized hydrogen peroxide (VHP), ozone, ultraviolet (UV) radiation, or dry heat are used. The application of various bio-decontamination equipment in industry is driving the market.

• The chamber decontamination segment accounted for the largest market share during the forecast period.

The Canada bio decontamination market is segmented by type into chamber decontamination and room decontamination. Among these, the chamber decontamination segment accounted for the largest market share during the forecast period. Entire enclosed spaces can be treated by chamber decontamination systems, guaranteeing thorough coverage of all surfaces and difficult-to-reach places by using mechanisms including aerosols, vaporization, or gaseous distribution. The application of chamber decontamination for sterilization especially in biopharmaceutical industry is propelling the market.

• The hydrogen peroxide segment is anticipated to hold the largest market share during the forecast period.

Based on the agent, the Canada bio decontamination market is divided into hydrogen peroxide, chlorine dioxide, peracetic acid, and nitrogen dioxide. Among these, the hydrogen peroxide segment is anticipated to hold the largest market share during the forecast period. Because of its broad-spectrum antibacterial activity, hydrogen peroxide can successfully eradicate a variety of microorganisms, such as bacteria, viruses, fungi, and spores without leaving any harmful residue or by-products. The adoption of hydrogen peroxide in water treatment and its widespread application are responsible for driving the market growth.

• The pharmaceutical & medical devices manufacturers segment dominated the Canada bio decontamination market with the largest market share in 2023.       

Based on the end user, the Canada bio decontamination market is divided into pharmaceutical & medical devices manufacturers, contract manufacturing & research organizations, hospital & healthcare facilities, and others. Among these, the pharmaceutical & medical devices manufacturers segment dominated the Canada bio decontamination market with the largest market share in 2023. Bio-decontamination systems including hydrogen peroxide vapor generators, UV-C disinfection devices, and ozone sterilizers are used in industries for efficiently eliminating biological contaminants. The high level of cleanliness required in the pharmaceutical industry for preventing health risks is driving the market demand.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Canada bio decontamination market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• STERIS Life Science
• Fedegari Group
• TOMI Environmental Solutions
• Bioquell
• JCE Biotechnology
• Noxilizer
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Canada, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Canada Bio Decontamination Market based on the below-mentioned segments:

Canada Bio Decontamination Market, By Product

• Equipment
• Consumables

Canada Bio Decontamination Market, By Type

• Chamber Decontamination
• Room Decontamination

Canada Bio Decontamination Market, By Agent

• Hydrogen Peroxide
• Chlorine Dioxide
• Peracetic Acid
• Nitrogen Dioxide

Canada Bio Decontamination Market, By End User

• Pharmaceutical & Medical Devices Manufacturers
• Contract Manufacturing & Research Organizations
• Hospital & Healthcare Facilities
• Others